Ninth Annual Translational Stem Cell Research Conference

Starts

October 22, 2014

Ends

October 23, 2014

October 22-23, 2014: NYSCF’s Ninth Annual Translational Stem Cell Conference will be held at The Rockefeller University in New York City.

NYSCF Conference Overview

The NYSCF conference is unique: it focuses on translational stem cell research, demonstrating the potential to advance cures for the major diseases of our time.

It is designed for all professionals with an interest in stem cell research, including physicians, researchers, clinical investigators, professors, government and health officials, postdoctoral fellows and graduate students. The panels on Wednesday are designed to reach a broader audience, including the lay public.

2014 Conference Schedule

WEDNESDAY, OCTOBER 22, 2014
Caspary Auditorium, The Rockefeller University

8:15 – 9:00 AM Registration and Complimentary Breakfast

9:00 – 9:05 AM Introduction – Susan L. Solomon, JD – The New York Stem Cell Foundation

9:05 – 9:10 AM Welcome Remarks – Marc Tessier-Lavigne, PhD – The Rockefeller University

ROAD TO THE CLINIC

09:10 AM – 10:40 AM Panel Discussion

Chair and Moderator
Lee Rubin, PhD – Harvard University

Panelists
Gabriela Burian, MD – Independent Advisor
Kenneth R. Chien, MD, PhD – Karolinska Institutet
Peter J. Coffey, DPhil – University College London, Institute of Opthalmology
Michele De Luca, MD – University of Modena and Reggio Emilia
Kiyotoshi Sekiguchi, PhD – Laboratory of Extracellular Matrix Biochemistry Institute for Protein Research, Osaka University

10:40 – 11:10 AM BREAK & POSTER SESSION

LARGE SCALE, BIG DATA: STEM CELL INNOVATION

11:10 AM – 12:30 PM Panel Discussion

Chair and Moderator
Susan L. Solomon, JD – The New York Stem Cell Foundation

Panelists
George M. Church, PhD – Harvard Medical School
John Greally, PhD – Albert Einstein College of Medicine
Scott Noggle, PhD – The NYSCF Research Institute
Eric Schadt, PhD – Icahn School of Medicine at Mount Sinai

12:30 – 1:35 PM COMPLIMENTARY LUNCH & POSTER SESSION

NEURODEGENERATION

Chair: Moses V. Chao, PhD – Skirball Institute, NYU

1:35– 1:55 PM Alison Goate, DPhil – Washington University School of Medicine
Studying genetically at risk populations to understand Alzheimer’s disease

2:00 – 2:20 PM Kevin C. Eggan, PhD – Harvard University
From patient specific iPS cell line to clinical drug trial for ALS

2:25 – 2:45 PM Lorenz Studer, MD – Memorial Sloan-Kettering Cancer Center
Manipulating in vivo function of human pluripotent stem cell grafts for Parkinson’s disease

2:50 – 3:10 PM BREAK & POSTER SESSION

REPROGRAMMING & CANCER

Chair: Ali H. Brivanlou, PhD – The Rockefeller University

3:10 – 3:30 PM Jacob Hanna, MD, PhD – Weizmann Institute of Science
Mechanisms for inducing, maintaining, and existing naive pluripotency

3:35 – 3:55 PM Catriona Jamieson, MD, PhD – University of California, San Diego
Targeted reversal of malignant reprogramming

4:00 –4:20 PM Michael Milone, MD, PhD – University of Pennsylvania
Building synthetic immunity to cancer using chimeric antigen receptors

4:25 –4:45 PM Ruth Lehmann, PhD – Helen L. and Martin S. Kimmel Center Stem Cell Biology, NYU School of Medicine
Mitochondrial localization and function in germ line stem cells

4:50 – 5:20 PM BREAK & POSTER SESSION

KEYNOTE ADDRESS

5:20 – 5:50 PM Sir Ian Wilmut, FRS, FRSE – University of Edinburgh
Development of a global induced pluripotent stem cell haplobank

PERSONALIZED MEDICINE: A CONVERSATION

5:55 – 6:40 PM Panel Discussion

Chair and Moderator
Susan L. Solomon, JD – The New York Stem Cell Foundation

Panelists
Dieter Egli, PhD – The NYSCF Research Institute
Rudolf Jaenisch, MD – The Whitehead Institute
Sir Ian Wilmut, FRS, FRSE – University of Edinburgh
THURSDAY, OCTOBER 23, 2014

Caspary Auditorium, The Rockefeller University

8:15 – 8:45 AM Registration and Complimentary Breakfast

8:45 – 8:50 AM Introduction – Susan L. Solomon, JD – The New York Stem Cell Foundation

8:50 – 9:00 AM Welcome Remarks – Kenneth Adams – Empire State Development Corporation

9:00 – 9:10 AM Welcome Remarks – Kyle Kimball – New York City Economic Development Corporation

DIABETES AND IMMUNITY

Chair: Shuibing Chen, PhD – Weill Cornell Medical College

9:10 – 9:30 AM Dan R. Littman, MD, PhD – Skirball Institute, NYU
Influence of the microbiota on host immunity, barrier function, and inflammation

9:35 – 9:55 AM Domenico Accili, MD – Columbia University Medical Center
Making insulin in the gut

10:00 – 10:20 AM Ludovic Vallier, PhD – University of Cambridge
hIPSCs to model inherited metabolic disorders

10:25 – 11:00 AM BREAK & POSTER SESSION

TRANSLATING INNOVATION
11:00 AM – 11:10 AM Chihiro Akazawa, MD, PhD – Program Officer for Japan Science and Technology Agency, and Graduate School of Health Care Sciences, Tokyo Medical and Dental University
The New Japanese Regulation for Regenerative Medicine

11:10 AM – 11:20 AM Michael Schuster, MS, BSc, MBA – Mesoblast
Mesoblast: From the benchside to the clinic to commercialization

11:20 AM – 11:30 AM Annie Moisan, PhD – Roche Pharma Research and Early Development
Stem cell-based screening platforms for drug discovery and predictive toxicology

11:30 AM – 11:45 AM Life Technologies
TBD

11:45 AM – 12:00 PM Stephen R. Chang, PhD – The NYSCF Research Institute
Richard Pearse, PhD – Harvard Catalyst – Eagle-I
NYSCF/Eagle-i collaboration: open access to stem cell lines

12:00 – 1:15 PM COMPLIMENTARY LUNCH & POSTER SESSION

GENERATING BLOOD

Chair: Ravi Majeti, MD, PhD – Stanford University

1:15 – 1:30 PM Ihor Lemischka, PhD – Icahn School of Medicine at Mount Sinai
Pluripotency and beyond

1:35 – 1:50 PM Shahin Rafii, MD – Weill Cornell Medical College
Direct reprogramming of adult endothelium into functional hematopoietic stem cells

1:55 – 2:10 PM Derrick J. Rossi, PhD – Harvard University
Making a hematopoietic stem cells: forwards and backwards

2:15 – 2:45 PM Generating Blood: A Conversation

2:45 – 3:15 PM BREAK & POSTER SESSION

HEART AND MUSCLES

Chair: Gordana Vunjak-Novakovic, PhD – Columbia University

3:15 – 3:35 PM Christine Mummery, PhD – Leiden University Medical Center
Human pluripotent stem cells as models for cardiac and vascular disease: the new patient?

3:40 – 4:00 PM Bruce Conklin, MD – Gladstone Institute, UCSF
Precise genome engineering disease phenotypes in human iPS cells

4:05 – 4:25 PM Chuck Murry, MD, PhD – University of Washington
Heart Regeneration

4:30 – 4:50 PM Gabsang Lee, PhD – John Hopkins University School of Medicine
Chemical compounds direct human pluripotent stem cells into patient-specific skeletal muscles

4:55 – 5:15 PM BREAK & POSTER SESSION

THE 2014 NYSCF – ROBERTSON STEM CELL PRIZE RECIPIENT ADDRESS

5:15 – 5:45 PM TBD

KEYNOTE ADDRESS

5:45 – 6:15 PM Rudolf Jaenisch, MD – The Whitehead Institute
iPS technology, gene editing and disease research

6:20 PM – CLOSING RECEPTION

Selected posters will be on display throughout the conference.